Pharmesis International (SGX:BFK) has proposed to undertake a capital reduction activity to reduce the share capital by cancellation of issued and fully paid-up share capital that has been lost or unrepresented by available assets.
The extent of the amount of accumulated losses are around SG$6.3 million, according to a filing with the Singapore Exchange on Monday.
The company will seek shareholders approval for the proposed capital reduction.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.